New Associate Dean for Academic Affairs Named
Richard Dalby, PhD, will lead the School’s educational programs, assessment and accreditation efforts and continuing pharmacy education
By Becky Ceraul
January 8, 2010
Richard Dalby, PhD, a professor of pharmaceutical sciences, has been named the University of Maryland School of Pharmacy’s associate dean for academic affairs. In this role, Dalby will have oversight of the School’s educational programs and will be responsible for assessment, accreditation, and continuing pharmacy education.
Dalby has been on faculty at the School of Pharmacy since 1992. He has chaired many of the School’s standing committees, has served as vice chair of the Department of Pharmaceutical Sciences and has twice been director of that department’s graduate program.
“Dr. Dalby has long been recognized as an innovator in education from his leadership role in the development and implementation of several required and elective courses, to his teaching awards, which include School of Pharmacy Teacher of the Year and Distinguished Educator of the Year,” says Natalie D. Eddington, PhD, dean of the School of Pharmacy. “His teaching and course management approach is grounded in practicality, inclusion of expert instructors across disciplines, and the creation of course management systems that endure beyond his tenure in a given position or class. I look forward to working with Dr. Dalby and know that he will bring energy, innovation, and experience to his new role as associate dean.”
In addition to his excellence in teaching, Dalby is an internationally recognized researcher and industry consultant in the area of nasal and pulmonary drug delivery systems. His most recent research achievements include the development of techniques to evaluate nasal spray bioequivalence, enhance drug delivery to the respiratory tract and elucidate powder emptying mechanisms from dry powder inhalers using physiologically justified inhalation conditions. His papers, books, patents, funding and student placement reflect his interest in patient-relevant testing on new and existing drug products. He has co-organized the Inhalation Aerosol Technology Workshop at the School of Pharmacy that has since 1993 attracted hundreds of attendees to the School. He is a fellow of the American Association of Pharmaceutical Sciences.
Says Dalby, “In this role, my goals are to simplify academic policies, ensure that the School of Pharmacy retains its accreditation during its next review in 2011 and 2012, collect assessment data that guides decision making, and support and explore ways that educational offerings can extend beyond the existing student body and generate shared revenue.”
Related News Stories
School of Pharmacy Sees Unparalleled Growth in Research Funding
December 7, 2015
New grants and contracts from a multitude of non-profit and government organizations, as well as the private sector, help the School of Pharmacy achieve the highest funding increase among all professional and graduate schools at the University of Maryland, Baltimore.
UMB Conducts First-of-a-Kind Study on Bioequivalency of Anti-Epileptic Drug
August 14, 2015
Collaborative study helps validate effectiveness of FDA’s bioequivalence standard, showing no significant differences between major brand name and generic medication used to treat patients with epilepsy.
SOP’s Polli Testifies for GDUFA Renewal at National Public Meeting
August 6, 2015
Testimony examined the impact of FDA-supported research in generic drugs and advocated for continued funding through renewal of the Generic Drug User Fee Amendments of 2012 (GDUFA).